| Dr Patrick Grimsley, MD | |
|
1700 E 19th St, The Dalles, OR 97058-3317 | |
| (541) 296-1111 | |
| Not Available |
| Full Name | Dr Patrick Grimsley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 25 Years |
| Location | 1700 E 19th St, The Dalles, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669416723 | NPI | - | NPPES |
| 200124 | Other | WA L & I | |
| 8351363 | Medicaid | WA | |
| 8906929 | Other | WA CRIME VICTIMS | |
| P00242144 | Other | RAILROAD | |
| 226824 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | DO24063 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clear Choice Dermatology | 4789005034 | 17 |
| Clear Choice Dermatology | 4789005034 | 17 |
News Archive
The ongoing COVID-19 pandemic changed the higher education experience for students across the United States, with more than 90 percent of institutions reporting a shift in education delivery with the arrival of COVID-19.
A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
At the European Society of Cardiology, ESC Congress 1 last weekend, Spanish researchers working as part of the long term project Seguimiento Universidad de Navarra (SUN) Project, presented their new study that suggests coffee intake might be tied to a longer life. The study included around 20,000 Spanish participants.
› Verified 1 days ago
| Entity Name | Mid-columbia Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053409599 PECOS PAC ID: 3779487251 Enrollment ID: O20031209000244 |
News Archive
The ongoing COVID-19 pandemic changed the higher education experience for students across the United States, with more than 90 percent of institutions reporting a shift in education delivery with the arrival of COVID-19.
A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
At the European Society of Cardiology, ESC Congress 1 last weekend, Spanish researchers working as part of the long term project Seguimiento Universidad de Navarra (SUN) Project, presented their new study that suggests coffee intake might be tied to a longer life. The study included around 20,000 Spanish participants.
› Verified 1 days ago
| Entity Name | Clear Choice Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891327185 PECOS PAC ID: 4789005034 Enrollment ID: O20200522001411 |
News Archive
The ongoing COVID-19 pandemic changed the higher education experience for students across the United States, with more than 90 percent of institutions reporting a shift in education delivery with the arrival of COVID-19.
A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
At the European Society of Cardiology, ESC Congress 1 last weekend, Spanish researchers working as part of the long term project Seguimiento Universidad de Navarra (SUN) Project, presented their new study that suggests coffee intake might be tied to a longer life. The study included around 20,000 Spanish participants.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick Grimsley, MD Po Box 4800, Unit 17, Portland, OR 97208-4800 Ph: (888) 633-0087 | Dr Patrick Grimsley, MD 1700 E 19th St, The Dalles, OR 97058-3317 Ph: (541) 296-1111 |
News Archive
The ongoing COVID-19 pandemic changed the higher education experience for students across the United States, with more than 90 percent of institutions reporting a shift in education delivery with the arrival of COVID-19.
A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.
Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has submitted additional patent applications, covering its Cobalamin-mediated oral drug delivery technology formulations of many global top-100 injectable drugs, as a result of the growing interest surrounding the company's proprietary oral delivery technology.
At the European Society of Cardiology, ESC Congress 1 last weekend, Spanish researchers working as part of the long term project Seguimiento Universidad de Navarra (SUN) Project, presented their new study that suggests coffee intake might be tied to a longer life. The study included around 20,000 Spanish participants.
› Verified 1 days ago
Dr. Erin Burnham, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Dr. Kathleen Baker Moore, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Dr. Richard Davis, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Dr. Deborah Vogel, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Dr. James Brent Sholar, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Dr. Jennifer Larson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 |